States Take on Drug Transparency, Gouging

States Take on Drug Transparency, Gouging

As the U.S. Congress continues to highlight specific drug price increases rather than adopt wide-reaching legislation to curb such practices, states are taking the matter into their own hands. In California, an Assembly committee on Wednesday moved forward a bill (SB 17) that would shine a spotlight on what the state spends on the most expensive prescription drugs, as well as which drugs have seen the highest year-over-year spending increases.

Source: ASCA/Regulatory Focus